Gut-Brain-Axis Therapeutics Inc. raised $1,965,000 (Tempe, AZ)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 15:17:01 GMT

Gut-Brain-Axis Therapeutics Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

62 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $39,300 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $1,965,000 so far.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • Incorporated in the last five years: likely still building out finance and insurance.
FieldValue
IndustryBiotechnology (Healthcare & Life Sciences)
Operating companyYes
Exemption506(c)
Amount sold$1,965,000
Total offering$20,000,000
Investors so far22
First sale2025-10-31
Filed2026-10-27 (amendment)
EntityCorporation, incorporated 2022

Executives and related persons (from the filing)

  • James B. Adams: Executive Officer, Director
  • Alexander Khoruts: Director
  • Rosa Krajmalnik-Brown: Director
  • Michael J. Sadowsky: Director

View the filing on SEC EDGAR

Markdown version

Gut-Brain-Axis Therapeutics Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
Gut-Brain-Axis Therapeutics Inc.Tempe$1,965,0002026-10-27
Swep Bio, Inc.Scarsdale$2,499,9892026-10-29
ZRMC Operating, LLCChandler$1,250,0002026-11-02
Tru Singular Health, Inc.Natick$1,000,0002026-10-30

Related records

Newly funded companies in Arizona (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.